Clinical trials
ARDS (Moderate or Severe) clinical trials
Below are recruiting ards (moderate or severe) clinical trials, each written for real people, not researchers. We’re tracking 1,471 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07560631Recruiting
Facial Tracking to Monitor Brain Injury Recovery
This study uses camera technology to track subtle facial movements as a way to detect awareness and recovery in people with severe brain injuries. It may help doctors better understand and monitor patients who have suffered traumatic brain injury.
Stony Brook, New YorkAges 22–85 - NCT07567625Recruiting
Heart Attack Treatment Without a Stent
This trial tests whether patients who have had a heart attack with a specific type of artery blockage can be safely treated without placing a metal stent (tube) in their artery. Doctors will monitor whether the blockage stays open on its own.
Harbin, HeilongjiangAges 18–75 - NCT07566624Recruiting
Registry study of Hydra heart valve replacement procedure
This study tracks patients who receive a Hydra artificial heart valve to replace a severely narrowed aortic valve. Researchers will follow your progress to understand how well the device works and its safety in real-world use.
Fuencarral-El PardoAges 18 years+ - NCT06643312Recruiting
Treadmill training with spinal stimulation for standing after spinal cord injury
This trial tests whether combining treadmill training with spinal cord stimulation (TPAD) can help people with severe spinal cord injuries regain the ability to stand. It aims to improve standing function and may lead to better recovery.
West Orange, New JerseyAges 18 years+ - NCT06738615Recruiting
Symptoms and severity of a leaky mitral valve study
This study looks at how symptoms relate to the severity of mitral regurgitation, a leaky heart valve. Researchers want to better understand the link between what you feel and the actual degree of the leak.
Morristown, New JerseyAges 18 years+ - NCT07554911Recruiting
Improving Treatment for Severe Dry Eye Disease
This study helps doctors find better ways to treat severe dry eye disease. Researchers will perform eye exams and ask questions to understand your condition better and optimize your care.
SingaporeAges 21–99 - NCT07554222RecruitingPhase 1
Safety study of IBI3013 for vitiligo and hair loss
This is an early-stage safety study of a new drug called IBI3013. The trial tests how safe the drug is and how your body processes it. It enrolls healthy volunteers first, then people with vitiligo (loss of skin color) or severe alopecia areata (patchy hair loss).
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07559396RecruitingPhase 1
Safety study of INCB123667 in adults with severe kidney disease
This study tests how a new experimental drug (INCB123667) works and is tolerated in adults with severe kidney problems or end-stage kidney disease. Researchers want to understand how the drug moves through the body and whether it's safe for people in your situation.
Miami Lakes, FloridaAges 18–85 - NCT07549178Recruiting
Mobile monitoring and care coordination for serious mental illness
This study tests whether combining extra care coordination with tracking data from your smartphone can help improve mental health care and reduce hospital visits. Researchers will use your smartphone to monitor your wellbeing while a care coordinator helps connect you with the support you need.
West Los Angeles, CaliforniaAges 18 years+ - NCT07551024Recruiting
Zygomatic Implant Placement Accuracy: Metallic vs Resin Guides
This study compares two types of surgical guides (metallic and resin-based) to help dentists place zygomatic implants—special dental anchors used when the upper jaw bone is severely worn down. The goal is to see which guide method places these implants more accurately.
New Cairo, Cairo GovernorateAges 18 years+ - NCT02431845Recruiting
Study of OCD genes, proteins, and gut microbes
This study looks at genes, blood/brain proteins, and gut microbes in people with obsessive-compulsive disorder (OCD). It may help researchers understand what drives OCD and how treatments could be better tailored in the future.
SeoulAges 19–70 - NCT07540754RecruitingPhase 1
How Your Liver Processes a New Injection Medicine
This study tests how your body processes a new medicine called HRS9531 when injected. Researchers want to understand how liver function affects the medicine's breakdown, which helps them determine safe doses for future patients.
Zhengzhou, HenanAges 18–65 - NCT07542366Recruiting
Testing a new lung imaging method in ICU patients
This study tests whether a special imaging technique called EIT (electrical impedance tomography) combined with a safe contrast injection can measure blood flow in the lungs of patients on breathing machines. If it works, it could help doctors better manage critically ill patients.
Wuhu, AnhuiAges 18 years+ - NCT07535593RecruitingPhase 2/Phase 3
Electrical Acupoint Stimulation for Consciousness Disorders
This trial tests a non-invasive treatment called transcutaneous electrical acupoint stimulation (TEAS) to help people recover consciousness after severe brain injury. The treatment uses mild electrical pulses on specific points on the hands and may help improve awareness and responsiveness.
Xi'an, ShaanxiAges 18–80 - NCT07542626Recruiting
Restoring Fertility by Transplanting Frozen Testicular Tissue
This trial tests whether transplanting frozen testicular tissue that was saved before cancer treatment can help men who cannot produce sperm have biological children. The tissue is thawed and put back into the testicles to restore natural sperm production.
BrusselsAges 18–40 - NCT07533006RecruitingPhase 2
Study of a new treatment for severe hair loss
This study tests an investigational drug to see if it can help people with severe alopecia areata, a condition that causes hair loss. It may help regrow hair.
Fremont, CaliforniaAges 18–60 - NCT07530770Recruiting
Benralizumab for Severe Asthma with Aspergillus Allergy
This study tests whether benralizumab, a biologic medicine, works well in real-world settings for people with severe asthma caused by an allergic reaction to a common mold called Aspergillus. You may qualify if you have hard-to-control asthma despite strong medications and recent asthma flare-ups.
Jinan, ShandongAges 18–75 - NCT07532551Recruiting
Online Therapy for Anxiety and Depression in Singapore
This study tests an internet-based cognitive behavioral therapy (a self-guided online mental health program) for people with mild-to-moderate anxiety or depression. You'd use an app on your phone or computer to work through lessons and exercises designed to help manage these feelings.
SingaporeAges 21 years+ - NCT06744244Recruiting
Smell test for newborns with birth asphyxia
This study tests whether a simple smell test can help doctors better understand the risk of brain injury in newborns who had oxygen loss at birth. It may help identify babies who need extra monitoring without requiring cooling treatment.
ParmaAges 6 hours–3 days - NCT06752304Recruiting
A long-term study of severe eating disorders
This study follows people with long-term eating disorders to understand how the condition changes over time. It may help researchers improve care for those who have struggled for years.
UppsalaAges 14 years+ - NCT06409689Recruiting
Oliceridine for pain relief after upper abdominal surgery
This study tests a new pain medicine called oliceridine after laparoscopic upper abdominal surgery. It aims to improve pain control and recovery compared to standard opioids.
Wuhan, HubeiAges 18–70 - NCT07524543Recruiting
Severe asthma registry study in Hong Kong
This study collects health information from adults with severe asthma to better understand the condition and improve treatment. Your participation involves sharing medical data to help researchers learn more about what works best for severe asthma.
Hong KongAges 18–120 - NCT07523646RecruitingPhase 4
Blood Boost for Patients With Heart Valve Infections
This study tests whether giving iron and a blood-boosting medicine (EPO) helps patients with bacterial heart valve infections who have low red blood cells. The goal is to see if it speeds recovery and improves how patients feel.
CopenhagenAges 18 years+ - NCT06705153Recruiting
Laughter yoga for irritable bowel syndrome
This study tests whether laughter yoga can help reduce IBS symptoms like belly pain and bloating, and also improve mood, sleep, and overall quality of life. You would join video calls where you practice special laughing exercises (no jokes needed) and then answer questionnaires.
Erzurum, YakutiyeAges 18–90
Hear when a new ARDS (Moderate or Severe) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ards (moderate or severe)?
- Yes. Clin2 currently lists 1,471 recruiting ards (moderate or severe) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ards (moderate or severe) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ards (moderate or severe) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.